{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:36:57Z","timestamp":1773308217608,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T00:00:00Z","timestamp":1222473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00403-008-0904-8","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T06:16:28Z","timestamp":1222409788000},"page":"21-25","source":"Crossref","is-referenced-by-count":30,"title":["Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients"],"prefix":"10.1007","volume":"301","author":[{"given":"Ali-Mohammad","family":"Namian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahmatolah","family":"Salmanpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Namazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farideh","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eskandar","family":"Kamali-Sarvestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,27]]},"reference":[{"key":"904_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0749.1994.tb00013.x","volume":"7","author":"MB Abdel Naser","year":"1994","unstructured":"Abdel Naser MB, Kr\u00fcger-Krasagakes S, Krasagakis K, Gollnick H, Orfanos CE (1994) Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 7:1\u20138","journal-title":"Pigment Cell Res"},{"key":"904_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/path.1711690205","volume":"169","author":"AM Al Badri","year":"1993","unstructured":"Al Badri AM (1993) Abnormal expression of MHC class ll and ICAM-l by melanocytes in vitiligo. J Pathol 169:203\u2013206","journal-title":"J Pathol"},{"key":"904_CR3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16:208\u2013214","journal-title":"Pigment Cell Res"},{"key":"904_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0190-9622(88)70168-1","volume":"19","author":"JL Bolognia","year":"1988","unstructured":"Bolognia JL, Pawelek JM (1988) Biology of hyperpigmentation. J Am Acad Dermatol 19:217\u2013255","journal-title":"J Am Acad Dermatol"},{"key":"904_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0923-1811(99)00029-8","volume":"21","author":"T Caixia","year":"1999","unstructured":"Caixia T, Hongwen F, Xiran L (1999) Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci 21:59\u201362","journal-title":"J Dermatol Sci"},{"key":"904_CR6","first-page":"37","volume":"32","author":"A Carnevale","year":"1980","unstructured":"Carnevale A, Zavala C, Castillo VD, Maldonado RR, Tamayo L (1980) Analisis genetico de 127 families con vitiligo. Rev Invest Clin 32:37\u201341","journal-title":"Rev Invest Clin"},{"key":"904_CR7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0738-081X(97)00125-9","volume":"15","author":"J Castanet","year":"1997","unstructured":"Castanet J, Ortonne JP (1997) Pathophysiology of vitiligo. Clin Dermatol 15:845\u2013851","journal-title":"Clin Dermatol"},{"key":"904_CR8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.0960-7420.2001.00281.x","volume":"29","author":"C Chevillard","year":"2002","unstructured":"Chevillard C, Henri S, Stefani F, Parzy D, Dessein A (2002) Two new polymorphisms in the human interferon gamma (IFN-gamma) promotor. Eur J Immunogenet 29:53\u201356","journal-title":"Eur J Immunogenet"},{"key":"904_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","volume":"51","author":"PE Grimes","year":"2004","unstructured":"Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A (2004) Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51:52\u201361","journal-title":"J Am Acad Dermatol"},{"key":"904_CR10","first-page":"534","volume":"98","author":"Wojdani A GrimesPE","year":"1992","unstructured":"GrimesPE Wojdani A, Loeb LJ, Franco R, Kelly AP (1992) The effects of isoprinosine treatment on repigmentation and immunologic aberrations in vitiligo. J Invest Dermatol 98:534","journal-title":"J Invest Dermatol"},{"key":"904_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/0001555563249251","volume":"63","author":"M Hafez","year":"1983","unstructured":"Hafez M, Sharaf L, Abd el-Nabi SM (1983) The genetics of vitiligo. Acta Derm Venereol 63:249\u2013251","journal-title":"Acta Derm Venereol"},{"key":"904_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1346-8138.1992.tb03211.x","volume":"19","author":"SK Hann","year":"1992","unstructured":"Hann SK, Park YK, Lee KG, Choi EH, Im S (1992) Epidermal changes in active vitiligo. J Dermatol 19:217\u2013222","journal-title":"J Dermatol"},{"key":"904_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang CL, Nordlund JJ, Boissy R (2002) Vitiligo. A manifestation of apoptosis. Am J Clin Dermatol 3:301\u2013308","journal-title":"Am J Clin Dermatol"},{"key":"904_CR14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","volume":"38","author":"SO Kovacs","year":"1998","unstructured":"Kovacs SO (1998) Vitiligo. J Am Acad Dermatol 38:647\u2013666","journal-title":"J Am Acad Dermatol"},{"key":"904_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","volume":"2","author":"IC Le Poole","year":"1993","unstructured":"Le Poole IC, Das PK, van den Wijngaard RM, Bos JD, Westerhof W (1993) Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 2:145\u2013153","journal-title":"Exp Dermatol"},{"key":"904_CR16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","volume":"100","author":"IC Le Pool","year":"1993","unstructured":"Le Pool IC, van den Wijngaard RM, Westerhof W, Dutrieux R, Das PK (1993) Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 100:816\u2013822","journal-title":"J Invest Dermatol"},{"key":"904_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/9780470760116.ch4","volume-title":"Vitiligo","author":"PP Majumder","year":"2000","unstructured":"Majumder PP (2000) Genetics and prevalence of vitiligo vulgaris. In: Hann S-K, Nordlund JJ (eds) Vitiligo. Blackwell, Oxford, pp 18\u201320"},{"key":"904_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1432-1327.1998.2550139.x","volume":"255","author":"M Martinez-Esparza","year":"1998","unstructured":"Martinez-Esparza M, Jimenez-Cervantes C, Solano F, Lozano JA, Garcia-Borron JC (1998) Mechanisms of melanogenesis inhibition by tumor necrosis factor-\u03b1 in B16\u2013F10 mouse melanoma cells. Eur J Biochem 255:139\u2013146","journal-title":"Eur J Biochem"},{"key":"904_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/1523-1747.ep12500086","volume":"97","author":"G Moellmann","year":"1982","unstructured":"Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB (1982) Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 97:321\u2013330","journal-title":"J Invest Dermatol"},{"key":"904_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/jid.1993.12","volume":"100","author":"JG Morelli","year":"1993","unstructured":"Morelli JG, Norris DA (1993) Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol 100:191\u2013195","journal-title":"J Invest Dermatol"},{"key":"904_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","volume":"15","author":"S Moretti","year":"2002","unstructured":"Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87\u201392","journal-title":"Pigment Cell Res"},{"key":"904_CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90\u2013100","journal-title":"Pigment Cell Res"},{"key":"904_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0749.1993.tb00584.x","volume":"6","author":"JP Ortonne","year":"1993","unstructured":"Ortonne JP, Bose SK (1993) Vitiligo: where do we stand? Pigment Cell Res 6:61\u201372","journal-title":"Pigment Cell Res"},{"key":"904_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2370.1999.00122.x","volume":"26","author":"V Pravica","year":"1999","unstructured":"Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchison IV (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26:1\u20133","journal-title":"Eur J Immunogenet"},{"key":"904_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","volume":"61","author":"V Pravica","year":"2000","unstructured":"Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-\u03b3 gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-\u03b3 production. Hum Immunol 61:863\u2013866","journal-title":"Hum Immunol"},{"key":"904_CR26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","volume":"13","author":"LA Rubin","year":"1990","unstructured":"Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor biology, function, and clinical application. Ann Intern Med 13:619\u2013627","journal-title":"Ann Intern Med"},{"key":"904_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000246657","volume":"190","author":"BA Salzer","year":"1995","unstructured":"Salzer BA, Schallreuter KU (1995) Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 190:109\u2013115","journal-title":"Dermatology"},{"key":"904_CR28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-4362.2003.01997.x","volume":"42","author":"A Taneja","year":"2003","unstructured":"Taneja A, Trehan M, Taylor CR (2003) Pharmacology and therapeutics. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 42:658\u2013662","journal-title":"Int J Dermatol"},{"key":"904_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2249.1994.tb06577.x","volume":"97","author":"GM Verjans","year":"1994","unstructured":"Verjans GM, Brinkman BM, VanDoornik CE, Kijlstra A, Verweij CL (1994) Polymorphism of tumor necrosis factor-alpha (TNF-alpha) at position \u2212308 in relation to ankylosing spondylitis. Clin Exp Immunol 97:45\u201347","journal-title":"Clin Exp Immunol"},{"key":"904_CR30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","volume":"83","author":"A Wa\u0144kowicz-Kali\u0144ska","year":"2003","unstructured":"Wa\u0144kowicz-Kali\u0144ska A, van den Wijngaard RM, Tigges BJ, Westerhof W, Ogg GS, Cerundolo V, Storkus WJ, Das PK (2003) Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest 83:683\u2013695","journal-title":"Lab Invest"},{"key":"904_CR31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","volume":"5","author":"AG Wilson","year":"1992","unstructured":"Wilson AG, de Giovine FS, Blakemore AL, Duff GW (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR producy. Hum Mol Gene 5:353","journal-title":"Hum Mol Gene"},{"key":"904_CR32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00403-006-0664-2","volume":"298","author":"AC Yazici","year":"2006","unstructured":"Yazici AC, Erdal ME, Kaya TI, Ikizoglu G, Savasoglu K, Camdeviren H, Tursen U (2006) Lack of association with TNF-alpha \u2212308 promoter polymorphism in patients with vitiligo. Arch Dermatol Res 298:46\u201349","journal-title":"Arch Dermatol Res"},{"key":"904_CR33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1523-1747.ep12478093","volume":"90","author":"JJ Yohn","year":"1990","unstructured":"Yohn JJ, Critelli M, Lyons MB, Norris DA (1990) Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 90:233\u2013237","journal-title":"J Invest Dermatol"},{"key":"904_CR34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000134119","volume":"71","author":"DB Zimonjic","year":"1995","unstructured":"Zimonjic DB, Rezanka LJ, Evans CH, Polymeropoulos MH, Trent JM, Popescu NC (1995) Mapping of the immune interferon gamma gene (IFNG) to chromosome band 12q14 by flourescence in situ hybridization. Cytogenet Cell Genet 71:247\u2013248","journal-title":"Cytogenet Cell Genet"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0904-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0904-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0904-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T23:01:41Z","timestamp":1709247701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0904-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0904-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,27]]}}}